Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging
Clinical trial NCT03303469 · TERMINATED
Trial details
- NCT number
- NCT03303469
- Sponsor
- University of Alabama at Birmingham
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-30
- Primary completion
- 2021-01-06
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.